Qube Research & Technologies (QRT)’s Precision BioSciences DTIL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Buy	+19,443	New	+$89.7K	﹤0.01%	3059
2024 Q3	–	Sell	-8	Closed	-$78	–	3494
2024 Q2	$78	Buy	8 +3	+60%	+$35	﹤0.01%	3452
2024 Q1	$68	Sell	5 -4	-44%	-$49	﹤0.01%	4201
2023 Q4	$93	Hold	9	–	–	﹤0.01%	4028
2023 Q3	$87	Buy	+9	New	+$138	﹤0.01%	3774
2023 Q2	–	Sell	-438	Closed	-$9.9K	–	2532
2023 Q1	$9.9K	Sell	438 -1,448	-77%	-$47.7K	﹤0.01%	2364
2022 Q4	$67.3K	Buy	1,886 +680	+56%	+$26.9K	﹤0.01%	2095
2022 Q3	$47K	Sell	1,206 -1,210	-50%	-$57.5K	﹤0.01%	2149
2022 Q2	$116K	Buy	+2,416	New	+$142K	﹤0.01%	1886
2022 Q1	–	Sell	-1,092	Closed	-$242K	–	2570
2021 Q4	$242K	Buy	+1,092	New	+$305K	﹤0.01%	1894

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DTIL Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Precision BioSciences (DTIL) in Q1 2026: 19,443 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #3059 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in DTIL as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in DTIL in Q4 2021 and has held it in 10 quarters since. The position peaked at $242K in Q4 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Qube Research & Technologies (QRT) held 19,443 shares of Precision BioSciences worth $107K as of Q1 2026.
Precision BioSciences was a new Qube Research & Technologies (QRT) position in Q1 2026.
Precision BioSciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3059 holding.
Qube Research & Technologies (QRT) first reported a position in Precision BioSciences in Q4 2021 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Precision BioSciences position peaked at $242K in Q4 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.